CO5160263A1 - Benzamidas sustituidas y medicamentos que las contienen - Google Patents
Benzamidas sustituidas y medicamentos que las contienenInfo
- Publication number
- CO5160263A1 CO5160263A1 CO99059817A CO99059817A CO5160263A1 CO 5160263 A1 CO5160263 A1 CO 5160263A1 CO 99059817 A CO99059817 A CO 99059817A CO 99059817 A CO99059817 A CO 99059817A CO 5160263 A1 CO5160263 A1 CO 5160263A1
- Authority
- CO
- Colombia
- Prior art keywords
- carbon atoms
- radical
- straight
- formula
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Benzamidas sustituidas de la fórmula I,<EMI FILE="99059817_1" ID="1" IMF=JPEG >en la cualR1 representa un grupo de la fórmula COOR4, en la cual R4 representa un radical alquilo de cadena recta o ramificada de 1 a 6 átomos de carbono o un grupo de la fórmula CONR5R6, en la cual R5 y R6 pueden ser iguales o distintos entre sí y representan un radical alquilo de 1 a 6 átomos de carbono de cadena recta o ramificada o conjuntamente con el átomo de nitrógeno representan un ciclo pirrolidina, piperidina, hexametilenimima o morfolina, R2 representa cloro, flúor, CF3, un radical alquilo de 1 a 3 átomos de carbono o hidrógeno, y R3 representa un radical hidroxilo, un radical alquilo o alcoxi de 1 a 6 átomos de carbono (de cadena recta o ramificada y eventualmente sustituido con OH, o un grupo alcoxi, éster o amida de cadena abierta o cíclica de 1 a 6 átomos de carbono) o un radical CH2-NR5R6, en el cual R5 y R6 tienen los significados arriba definidos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843793A DE19843793C2 (de) | 1998-09-24 | 1998-09-24 | Substituierte Benzamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5160263A1 true CO5160263A1 (es) | 2002-05-30 |
Family
ID=7882078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99059817A CO5160263A1 (es) | 1998-09-24 | 1999-09-21 | Benzamidas sustituidas y medicamentos que las contienen |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6080742A (es) |
| EP (1) | EP0989121B1 (es) |
| JP (1) | JP2000095761A (es) |
| KR (1) | KR20000023339A (es) |
| CN (1) | CN1126741C (es) |
| AR (1) | AR021814A1 (es) |
| AT (1) | ATE309987T1 (es) |
| AU (1) | AU750919B2 (es) |
| BR (1) | BR9906070A (es) |
| CA (1) | CA2283021A1 (es) |
| CO (1) | CO5160263A1 (es) |
| CZ (1) | CZ295496B6 (es) |
| DE (2) | DE19843793C2 (es) |
| DK (1) | DK0989121T3 (es) |
| ES (1) | ES2251143T3 (es) |
| HK (1) | HK1026211A1 (es) |
| HU (1) | HUP9903216A3 (es) |
| IL (1) | IL132012A (es) |
| NO (1) | NO312671B1 (es) |
| NZ (1) | NZ337531A (es) |
| PE (1) | PE20001050A1 (es) |
| PL (1) | PL194897B1 (es) |
| RU (1) | RU2221783C2 (es) |
| SI (1) | SI0989121T1 (es) |
| SK (1) | SK283316B6 (es) |
| UY (1) | UY25712A1 (es) |
| ZA (1) | ZA996133B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10002509A1 (de) | 2000-01-21 | 2001-07-26 | Gruenenthal Gmbh | Substituierte Glutarimide |
| WO2001070688A2 (de) * | 2000-03-20 | 2001-09-27 | Grünenthal GmbH | N-(2,6-dioxo-piperidin-3-yl) benzamide und ihre verwendung als immunomodulatoren |
| US20050226845A1 (en) * | 2004-03-10 | 2005-10-13 | Chih-Ping Liu | Method of treatment using interferon-tau |
| US7431920B2 (en) * | 2000-07-19 | 2008-10-07 | Pepgen Corporation | Method of treating IL-10 deficiency |
| US20050118138A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
| US20050201981A1 (en) * | 2004-03-10 | 2005-09-15 | Chih-Ping Liu | Method of optimizing treatment with interferon-tau |
| US20050084478A1 (en) * | 2000-10-17 | 2005-04-21 | Chih-Ping Liu | Combination therapy using interferon-tau |
| US20040247565A1 (en) * | 2000-07-19 | 2004-12-09 | Chih-Ping Liu | Method of treatment using interferon-tau |
| US20050118137A1 (en) * | 2000-07-19 | 2005-06-02 | Chih-Ping Liu | Method of treatment using interferon-tau |
| EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| ES2338534T3 (es) * | 2001-02-27 | 2010-05-10 | The Governement Of The Usa, Represented By The Secretary Department Of Health And Human Services | Analogos de talidomina como inhibidores de la angiogenesis. |
| US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
| WO2003037365A1 (en) * | 2001-11-01 | 2003-05-08 | The Johns Hopkins University | Methods and compositions for treating vascular leak using hepatocyte growth factor |
| DE10163595A1 (de) * | 2001-12-21 | 2003-08-07 | Gruenenthal Gmbh | In 3-Position heterocyclisch substituierte Piperidin-2,6-dione |
| US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
| CN1867331B (zh) | 2003-09-17 | 2010-05-26 | 美国政府健康及人类服务部 | 作为TNF-α调节剂的沙利度胺类似物 |
| US20060078942A1 (en) * | 2004-03-10 | 2006-04-13 | Pepgen Corporation | Method of treatment using interferon-tau |
| US20080025948A1 (en) * | 2004-03-10 | 2008-01-31 | Chih-Ping Liu | Methods of Treatment Using Interferon-Tau |
| DE102004026703A1 (de) * | 2004-05-28 | 2005-12-29 | Grünenthal GmbH | Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen |
| AU2007238785B2 (en) * | 2006-04-13 | 2013-02-07 | Agnieszka Ambrozak | Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| US8314107B2 (en) | 2008-04-23 | 2012-11-20 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds and methods for using the same |
| US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
| KR102316961B1 (ko) * | 2020-01-29 | 2021-10-26 | 프라비바이오 주식회사 | 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545672B2 (de) * | 1965-05-08 | 1974-11-07 | Chemie Gruenenthal Gmbh, 5190 Stolberg | Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung |
-
1998
- 1998-09-24 DE DE19843793A patent/DE19843793C2/de not_active Expired - Fee Related
-
1999
- 1999-08-27 NZ NZ337531A patent/NZ337531A/xx not_active IP Right Cessation
- 1999-09-03 EP EP99117319A patent/EP0989121B1/de not_active Expired - Lifetime
- 1999-09-03 DE DE59912795T patent/DE59912795D1/de not_active Expired - Lifetime
- 1999-09-03 ES ES99117319T patent/ES2251143T3/es not_active Expired - Lifetime
- 1999-09-03 DK DK99117319T patent/DK0989121T3/da active
- 1999-09-03 SI SI9930863T patent/SI0989121T1/sl unknown
- 1999-09-03 AT AT99117319T patent/ATE309987T1/de active
- 1999-09-15 UY UY25712A patent/UY25712A1/es unknown
- 1999-09-17 AR ARP990104701A patent/AR021814A1/es unknown
- 1999-09-17 PE PE1999000942A patent/PE20001050A1/es not_active Application Discontinuation
- 1999-09-21 KR KR1019990040635A patent/KR20000023339A/ko not_active Application Discontinuation
- 1999-09-21 CO CO99059817A patent/CO5160263A1/es unknown
- 1999-09-22 JP JP11269084A patent/JP2000095761A/ja not_active Withdrawn
- 1999-09-22 AU AU48861/99A patent/AU750919B2/en not_active Ceased
- 1999-09-22 HU HU9903216A patent/HUP9903216A3/hu unknown
- 1999-09-22 CA CA002283021A patent/CA2283021A1/en not_active Abandoned
- 1999-09-23 RU RU99120663/04A patent/RU2221783C2/ru not_active IP Right Cessation
- 1999-09-23 BR BR9906070-1A patent/BR9906070A/pt not_active IP Right Cessation
- 1999-09-23 IL IL13201299A patent/IL132012A/en not_active IP Right Cessation
- 1999-09-23 ZA ZA9906133A patent/ZA996133B/xx unknown
- 1999-09-23 NO NO19994626A patent/NO312671B1/no not_active IP Right Cessation
- 1999-09-23 SK SK1308-99A patent/SK283316B6/sk not_active IP Right Cessation
- 1999-09-23 PL PL335555A patent/PL194897B1/pl not_active IP Right Cessation
- 1999-09-23 CN CN99120232A patent/CN1126741C/zh not_active Expired - Fee Related
- 1999-09-23 CZ CZ19993386A patent/CZ295496B6/cs not_active IP Right Cessation
- 1999-09-24 US US09/405,180 patent/US6080742A/en not_active Expired - Lifetime
-
2000
- 2000-09-01 HK HK00105496A patent/HK1026211A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5160263A1 (es) | Benzamidas sustituidas y medicamentos que las contienen | |
| EA199700246A1 (ru) | N-ариламинопиперидин-n-оксилы | |
| SE8704599D0 (sv) | Teobrominderivat | |
| IS6309A (is) | Kínasólínafleiður | |
| DE69116127T2 (de) | Piperazinderivate | |
| EA199800768A1 (ru) | Новые производные эритромицина, способ их получения и их применение в качестве медикаментов | |
| EA200500862A1 (ru) | Синоменин и соединения синоменина, синтез и применение | |
| DE3866646D1 (de) | 1-((2-pyrimidinyl)-aminoalkyl)-piperidine, deren herstellung und verwendung als heilmittel. | |
| DK428989D0 (da) | Benzylaminderivater | |
| DE3875346D1 (de) | Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten. | |
| MY100115A (en) | Nitrogen containing heterocyclic compounds, and their production and use. | |
| EA200200810A1 (ru) | Конденсированные соединения азола и их применение в качестве гипогликаемических агентов | |
| ES2110720T3 (es) | Inhibidores biarilicos de la fosfolipasa a2. | |
| DE58906941D1 (de) | Fluorsubstituierte Benzolderivate. | |
| MX9203360A (es) | Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen. | |
| DE59007487D1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| EA199800366A1 (ru) | Способы ингибирования ингибитора 1 активатора плазминогена | |
| CO4950613A1 (es) | Derivados de benzoxazindiona y medicamentos que los contienen | |
| FI971177A (fi) | Bisyklisiä karboksiamideja 5-HT1A-antagonisteina | |
| NO922523L (no) | Aminopyrimidinkarboksamiddrivater med terapeutisk virkning | |
| MA20552A1 (fr) | Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations | |
| DE69107877T2 (de) | Stabilisierung von Methacrylatpolymeren gegen sterilisierende Strahlung. | |
| KR900004690A (ko) | 1,4-디히드로피리딘 유도체 | |
| FR2647786B1 (fr) | Nouveaux composes a fonction dihydropyridine | |
| CO4970778A1 (es) | Nuevos compuestos |